| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Vascular Physiology Group, Department of Cell Biology and Physiology, University of New Mexico School of Medicine, Albuquerque, New Mexico 87131-5218
 |
ABSTRACT |
|---|
Top
Abstract
Introduction
Methods
Results
Discussion
References
|
|---|
Chronic hypoxic
exposure has been previously demonstrated to attenuate systemic
vasoconstrictor activity to a variety of agents. This attenuated
responsiveness is observed not only in conscious animals but in
isolated vascular preparations as well. Because hypoxia has been
documented to increase heme oxygenase (HO) levels and the subsequent
production of the vasodilator CO in vitro, we hypothesized that the
blunted reactivity observed with chronic hypoxia (CH) may be in part
due to increased HO activity. In thoracic aortic rings from CH rats,
cumulative dose-response curves to phenylephrine (PE) in the presence
of the nitric oxide (NO) synthase inhibitor
N
-nitro-L-arginine
(L-NNA) and the HO inhibitor
zinc protoporphyrin 9 (ZnPPIX) elicited increased contractility
compared with CH rings treated with only
L-NNA. Similar results were
observed in rings incubated overnight with the HO-inducing agent sodium
m-arsenite. In contrast, contractile
responses in rings from control rats were unaffected by the HO
inhibitor. Furthermore, endothelium-denuded rings from either control
or CH rats did not exhibit an increase in reactivity to PE following
ZnPPIX incubation. ZnPPIX had no effect on relaxant responses to the NO
donor
S-nitroso-N-penicillamine, suggesting that its actions were specific to HO inhibition. Finally, aortic rings exhibited dose-dependent relaxant responses to exogenous CO that were endothelium independent and blocked by an inhibitor of
soluble guanylyl cyclase. The other products of HO enzyme activity, iron and biliverdin, were without effect on vasoreactivity. Thus we
conclude that the attenuated vasoreactivity to PE following CH is
likely to involve the induction of endothelial HO and the subsequent
enhanced production of CO.
rat; thoracic aorta; heme oxygenase; nitric oxide synthase; endothelium
| |
INTRODUCTION |
|---|
|
Top
Abstract
Introduction
Methods
Results
Discussion
References
|
|---|
PREVIOUS STUDIES FROM our laboratory and others have
documented attenuated systemic vasoreactivity to various pressor agents following chronic exposure to hypoxia (5, 9, 10). Such diminished
pressor responsiveness could have a significant effect on control of
blood pressure in hypoxemic pulmonary disorders (8) and during
residence at high altitude. Altered vasoreactivity following chronic
hypoxia (CH) has been demonstrated in both whole animal and isolated
vessel preparations, suggesting that at least part of this mechanism
resides at the level of the vasculature (5). Whether this response is
associated with decreased vascular smooth muscle sensitivity to
vasoconstrictors or to stimulated release of endogenous vasodilators
has not been fully defined. Recent findings suggest that CH decreases
1-adrenergic receptor density
and agonist binding affinity (9), inhibits
receptor-effector-contraction coupling (10), and diminishes arteriolar
contraction in response to
2D-adrenoreceptor stimulation
(19). These results support a role of altered vascular smooth muscle
function following CH exposure, which could account for decreased
pressor sensitivity. Alternatively, the endothelium is a well-known
modulator of vascular tone, which has also been implicated in the
CH-induced reduction in vasoreactivity. For example, previous studies
have demonstrated increased production of endothelium-derived
vasodilatory prostaglandins (6) and adenosine (15) following extended
hypoxic exposure. Furthermore, endothelial nitric oxide (NO) synthase
(NOS) levels appear to be elevated in the pulmonary circulation in
response to CH (17). It is well characterized that endothelium-derived NO diffuses to the underlying vascular smooth muscle and causes relaxation. Recently, CO, a product of heme oxygenase (HO), has been
characterized as an endogenous vasoactive molecule analogous to NO
(13). Both diatomic molecules bind soluble guanylyl cyclase (sGC),
facilitating increased cGMP production (2, 13) and subsequent vascular
smooth muscle relaxation. There has been speculation that HO-generated
CO may play a physiological role in blood pressure regulation (11, 21).
This is supported by the recent observation that zinc protoporphyrin 9 (ZnPPIX), a potent inhibitor of HO, causes diminished CO production and
elevated vascular resistance in the rat hepatic microcirculation (18).
There is also evidence for HO-catalyzed CO formation in rat aortic
tissue (4), and relaxation in response to CO has been demonstrated in
rat coronary (14) and in canine coronary, femoral, and carotid artery
preparations (20). Interestingly, hypoxia causes hypoxia-inducible
factor 1-mediated transcriptional activation of the HO-1 gene (12), increasing HO-1 mRNA levels and production of cGMP in cultured rat
aortic smooth muscle cells (16). These observations support our
hypothesis that enhanced release of CO may contribute to the diminished
responsiveness to vasoconstrictors observed after prolonged hypoxic
exposure.
The current study examined the role of CO in the reduced vasoconstrictor reactivity seen in aortic tissue from rats exposed to CH. Our data suggest that enhanced production of endothelium-derived CO likely contributes to CH-mediated attenuation of vasoreactivity to adrenergic stimulation in this preparation.
| |
METHODS |
|---|
|
Top
Abstract
Introduction
Methods
Results
Discussion
References
|
|---|
All protocols employed in this study were reviewed and approved by the Institutional Animal Care and Use Committee of the University of New Mexico School of Medicine.
Experimental Groups
Male Sprague-Dawley rats (250-300 g; Harlan) were divided into CH and control groups. Rats in the CH group were housed in a hypobaric chamber maintained at 380 mmHg, whereas rats in the control group were housed at ambient barometric pressure (~630 mmHg). CH rats were acclimated to hypobaria for 4 wk before experimentation. The chamber was briefly opened three times per week to provide animals with clean bedding and fresh food and water.Aortic Ring Preparation
Rats were anesthetized with pentobarbital sodium (50 mg/kg ip), and the descending thoracic aorta was isolated and placed in 5°C physiological saline solution (PSS) containing (in mM) 129.8 NaCl, 5.4 KCl, 0.83 MgSO4, 0.4 NaH2PO4, 19 NaHCO3, 1.8 CaCl, and 5.5 glucose (all from Sigma) (pH 7.4). Once cleaned of adventitia, the aorta was cut into six to seven 3-mm segments. Endothelium was removed in some rings by gently rubbing the lumen with closed forceps tips. Aortic rings were threaded between two 600-µm-diameter hooks and suspended in tissue baths (37°C) filled with 20 ml PSS. The top hook was connected to a Grass FT03 force-displacement transducer, and the bottom hook was anchored to an immovable support. Tissue baths were continuously bubbled with a 21% O2-5.5% CO2-balance N2 gas mixture. Rings were stretched to resting tension of 1.5 g and allowed to equilibrate for 60 min before experimentation.Demonstration of Attenuated Vasoreactivity to Phenylephrine in Aortic Rings from CH Rats
After equilibration, endothelium-intact rings from control and CH rats were challenged with the1-adrenoceptor agonist
phenylephrine (PE; 1 µM). At the peak of contraction, endothelial
integrity was verified by noting the relaxant response to ACh (10 µM). In endothelium-intact rings, at least 50% relaxation was
necessary for inclusion in experiments. Relaxation in response to ACh
averaged 97.06 ± 7.66% (control) and 91.04 ± 5.34% (CH). Rings
were rinsed with PSS and returned to baseline tension, followed by
generation of a concentration-response curve to PE
(10
10-103
M).
Effect of HO Blockade on PE Responsiveness in Aortic Rings From Control and CH Rats
To determine whether endogenously produced CO contributes to reduced contractile responsiveness following CH, PE concentration-response curves were generated in aortic rings from each group of animals after treatment with the HO inhibitor ZnPPIX. All experiments were performed in the presence of the NOS inhibitor N-nitro-L-arginine
(L-NNA; 100 µM) (7) to
eliminate any confounding effects of NO. After initial contraction and
endothelial test, a concentration-response curve to PE was generated as
a further test of ring viability. Rings were next rinsed, followed by a 1-h incubation with either ZnPPIX (10 µM) + L-NNA (100 µM) or vehicle + L-NNA (100 µM). Due to the
photosensitivity of protoporphyrin compounds, all rings in this and
subsequent experiments were incubated in the dark, inside foil-wrapped
baths. After the incubation period, a second concentration-response
curve was generated.
Role of Endothelium in Generating CO in Aortic Rings from Control and CH Rats
Experiments were performed using endothelium-denuded vessels to determine the potential contribution of endothelium-derived CO in attenuated vasoreactivity following CH. The experimental design was identical to the preceding protocol except that ZnPPIX and its vehicle were administered in the absence of L-NNA. In endothelium-denuded rings, relaxation in response to ACh averaged 2.04 ± 3.18% (control) and 1.87 ± 3.35% (CH).Efficacy and Specificity of ZnPPIX Inhibition of HO Activity
Additional experiments were conducted to test the effectiveness and selectivity of ZnPPIX in this preparation.Effectiveness of ZnPPIX in sodium m-arsenite-treated aortic rings. To establish the efficacy of ZnPPIX in blocking HO activity, endothelium-intact control aortic rings were incubated for 18 h in minimum essential medium (Sigma) containing either 12.5 µM sodium m-arsenite, an agent shown to enhance HO-1 gene expression (2), or its vehicle. After incubation, rings were treated for 1 h with either ZnPPIX (10 µM) + L-NNA (100 µM) or vehicle + L-NNA (100 µM) as above, and a PE concentration-response curve was generated.
Specificity of ZnPPIX. Whereas ZnPPIX
is a potent inhibitor of HO activity, at higher concentrations it may
also inhibit NOS and sGC activities (25). Because our experiments
eliminate the contribution of NO by administration of an NOS inhibitor
or by physical endothelial removal, any nonspecific actions of ZnPPIX on NOS activity are not of concern. However, to confirm that the actions of ZnPPIX were not due to inhibition of sGC, we performed additional experiments examining the effects of the inhibitor on
relaxation due to stimulation of sGC by the NO donor
S-nitroso-N-acetylpenicillamine (SNAP). After incubation for 1 h with either ZnPPIX (10 µM;
n = 5) or vehicle
(n = 6), endothelium-intact aortic
rings from control rats were contracted with
104 M PE and cumulative
vasorelaxant responses to
108-104
M SNAP were determined.
Vasorelaxant Responses to HO Products
Experiments were performed to evaluate the ability of CO to elicit relaxation in PE-contracted aortic rings from control rats. Both endothelium-intact (n = 5) and -denuded (n = 4) aortic rings were contracted with 1 µM PE and then administered increasing volumes of PSS equilibrated with CO gas. The CO solution was prepared by bubbling CO gas into sealed, air-tight glass test tubes containing PSS for 3 min on ice. The saturated solution was drawn into Hamilton gas-tight glass syringes, and increasing volumes were added quickly to the PSS in the tissue baths containing the contracted arteries. CO relaxations reached a plateau in 2 min and then the next volume of saturated solution was added (10-2,500 µl to a 25-ml bath volume). Additional experiments examined responses of intact (n = 5) and denuded (n = 4) rings to CO in the presence of the sGC inhibitor 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ, 10 µM). In addition to CO, the metabolism of heme by HO also produces biliverdin and iron. Thus experiments were performed to evaluate the ability of these products to reverse PE contraction in endothelium-intact aortic segments. After a stable contraction was established, increasing concentrations of FeCl2 (n = 3), FeCl3 (n = 3), and biliverdin (n = 3) were added and the change in tension was recorded.Solutions
All experimental drugs were prepared on the day of experimentation. PE and acetylcholine (Sigma) were dissolved in normal saline. L-NNA, sodium m-arsenite, FeCl2, FeCl3, and biliverdin (all from Sigma) were dissolved in water, whereas ZnPPIX (Porphyrin Products) was dissolved in normal saline containing 5 mM Na2CO3. SNAP (Cayman) was first dissolved in ethanol and diluted with water. ODQ (Calbiochem) was dissolved in DMSO and diluted with PSS. Final minimum essential medium contains 10.2 g-MEM (Sigma), 0.02 M HEPES buffer (Sigma),
0.05 M NaHCO3 (Sigma), and 2.4%
penicillin-streptomycin (Life Technologies).
Calculations and Statistics
For contractile experiments, maximum tensions for PE were compared by either Student's t-test or a two-way ANOVA. If differences were detected by ANOVA, individual groups were compared using the Student-Newman-Keuls test. SigmaPlot (Jandel Scientific) was used to perform a nonlinear regression analysis on each individual ring experiment to calculate EC50 values. Vasorelaxant responses for SNAP and CO were calculated as percent reversal of maximum PE-induced contraction. Percent data underwent arcsine transformation before statistical analysis. Results were compared by Student's t-test. Data are presented as means ± SE. Differences were considered significant if P
0.05.
| |
RESULTS |
|---|
|
Top
Abstract
Introduction
Methods
Results
Discussion
References
|
|---|
Demonstration of Attenuated Vasoreactivity in Aortic Rings From CH Rats
Figure 1 shows concentration-response curves to PE in endothelium-intact aortic rings from control (n = 7) and CH (n = 6) rats. As we have previously shown (6), aortic rings from CH rats exhibited attenuated contractile responses to pressor agents compared with control rings. However, EC50 values did not differ between control (1.87 ± 0.53 × 107 M) and CH (2.37 ± 0.28 × 107 M) groups.
|
Effect of HO Blockade
Figure 2 shows PE concentration-response curves for aortic rings pretreated with either L-NNA and ZnPPIX or L-NNA and vehicle from both control (n = 7) and CH (n = 6) rats. Rings from both control and CH rats treated with L-NNA alone appeared to exhibit greater contractility than untreated rings in the previous protocol (Fig. 1), although these groups were not statistically compared because of differences in the protocol design. Interestingly, however, L-NNA-treated rings from CH rats still demonstrated reduced responsiveness to PE compared with similarly treated control rings, suggesting involvement of an NO-independent mechanism in the sustained alteration in reactivity following hypoxia. HO inhibition with ZnPPIX had no effect on contractile responses to PE in rings from control rats, and EC50 values of concentration-response curves did not differ between L-NNA + ZnPPIX (5.39 ± 0.85 × 108 M) and
L-NNA + vehicle (5.11 ± 0.76 × 108 M) groups.
However, aortic rings from CH rats incubated with L-NNA and ZnPPIX exhibited
increased contractility compared with those incubated with
L-NNA and vehicle, suggesting
that HO-derived CO plays a role in diminished vasoreactivity in rings
from CH rats. EC50 values of
concentration-response curves did not differ between
L-NNA + ZnPPIX (4.53 ± 0.45 × 108 M) and
L-NNA + vehicle (5.63 ± 0.62 × 108 M) groups of
aortic rings from CH rats.
|
Role of Endothelium in Generating CO
After incubation with either ZnPPIX or vehicle, endothelium-denuded aortic rings from control (n = 7) and CH (n = 6) rats showed no difference in vascular responsiveness to PE (Fig. 3). This finding suggests that HO-generated CO, which appears to play a role in diminished vascular responsiveness following CH, is produced by the endothelium. Neither the EC50 values of the concentration-response curves from control [2.92 ± 0.51 × 108 M (ZnPPIX) vs. 4.37 ± 0.77 × 108 M
(vehicle)] nor CH [3.06 ± 0.59 × 108 M (ZnPPIX) vs. 3.49 ± 1.06 × 108 M
(vehicle)] aortas were different.
|
Efficacy and Specificity of ZnPPIX Inhibition of HO Activity
Effectiveness of ZnPPIX in sodium m-arsenite-treated aortic rings. After incubation with 12.5 µM sodium m-arsenite, aortic rings treated with ZnPPIX and L-NNA (n = 6) exhibited significantly greater contractility to PE than rings treated with vehicle and L-NNA (n = 6) (Fig. 4A). EC50 values did not differ between L-NNA + ZnPPIX (5.69 ± 0.94 × 108 M) and
L-NNA + vehicle (5.72 ± 0.62 × 108 M) groups. In
contrast, no differences in contractility were observed between groups
treated with the vehicle for sodium
m-arsenite (n = 6) (Fig.
4B).
EC50 values of
concentration-response curves also did not differ in these control
rings between L-NNA + ZnPPIX (6.18 ± 1.04 × 108
M) and L-NNA + vehicle (5.10 ± 0.89 × 108 M) groups.
These data demonstrate the efficacy of ZnPPIX as an HO inhibitor in
this preparation.
|
Specificity of ZnPPIX. Vasorelaxant responses to SNAP in control rings pretreated with either ZnPPIX (n = 5) or its vehicle (n = 6) are shown in Fig. 5. There were no differences between groups in vasorelaxant responses or in the amount of tension initially generated by PE (0.54 ± 0.12 vs. 0.53 ± 0.04 g/mg tissue, respectively). The data strongly suggest that 10 µM ZnPPIX does not affect sGC activity in this preparation.
|
Vasorelaxant Responses to HO Products
Administration of CO-equilibrated PSS to PE-contracted rings elicited similar dose-dependent relaxant responses in both endothelium-intact and -denuded aortic rings (Fig. 6). Both responses were completely eliminated in the presence of 10 µM of the sGC inhibitor ODQ (Fig. 6). In contrast, FeCl2, FeCl3, and biliverdin were without effect on PE contraction in endothelium-intact rings.
|
| |
DISCUSSION |
|---|
|
Top
Abstract
Introduction
Methods
Results
Discussion
References
|
|---|
The major findings of the present study are 1) the HO inhibitor ZnPPIX augments contractile responses to PE in L-NNA-treated aortic rings from CH rats but not controls, 2) administration of ZnPPIX causes no change in contractility in endothelium-denuded aortic rings from either control or CH rats, 3) 10 µM ZnPPIX does not affect NO-dependent vasorelaxation, and 4) exogenous CO elicits vasorelaxation in control aortic rings that is blocked by an inhibitor of sGC. These data suggest that increased aortic endothelial HO activity contributes to the decreased vasoreactivity to PE following exposure to CH.
Recently, a hypoxia-responsive element has been identified in the mouse HO-1 gene (12), and the expression of hypoxia-inducible factor 1 has been implicated in mediating hypoxia-induced HO-1 expression. After a CH stimulus, Northern blotting has shown a fivefold increase in HO-1 mRNA levels in rat aorta (12) and a sevenfold increase in HO-1 mRNA levels in cultured rat aortic smooth muscle cells (16). These findings, coupled with data implicating a physiological role for CO in vascular control (11, 24), suggest that a portion of the altered vasoreactivity following CH may be linked to increased production of CO. Compared with NOS blockade alone, the increase in contractility to PE following combined NOS and HO blockade in endothelium-intact aortas from CH rats suggests that levels of HO enzyme and/or activity are increased in these vessels. However, inhibition of both NOS and HO returned contractile responses to levels still slightly below their corresponding controls, which may be interpreted as evidence for involvement of other factors such as alterations in smooth muscle sensitivity to vasoconstrictors or an increase in release of other vasodilatory compounds in the attenuation of reactivity following CH.
From our initial observations, it was unclear whether the apparent increase in HO activity following CH was localized to the endothelial or vascular smooth muscle layer. Previous studies have shown that inhibition of HO activity by another HO inhibitor, tin protoporphyrin 9, reverses the component of endothelium-dependent relaxation of porcine distal pulmonary arteries not reversed by an inhibitor of NOS (25). Thus CO, like NO, may contribute to endothelium-dependent vasorelaxation in the pulmonary circulation. Immunocytochemical localization of HO-1 expression in rat aorta after lipopolysaccharide (LPS) administration revealed increased staining in both the endothelial and vascular smooth muscle layers (24), and ZnPPIX caused a reduction of LPS-induced hypotension. In addition, HO-1 has been localized by immunological staining to the endothelial layer of the sheep ductus arteriosus (3). Our results suggest that the endothelium, but not vascular smooth muscle, produces physiologically relevant NO and CO in the rat aorta following CH. The observation that exogenous CO elicits endothelium-independent vasorelaxation in aortic rings suggests that the response to CO indeed resides within the smooth muscle and is not due to the secondary release of a separate endothelium-derived dilator. Furthermore, our findings confirm a primary role of activation of sGC in the vascular response to CO. We speculate that CO, like NO, acts in a paracrine manner to affect the underlying vascular smooth muscle.
Because ZnPPIX is not specific for either the HO-1 or HO-2 isozyme of HO, it is uncertain which isoform is being affected by the inhibitor in our study. HO-2 is abundant in the brain, testes, and endothelial lining of the aorta (25). This isoform is generally considered to be constitutive (25), although its expression can be induced by glucocorticoids (13). However, because hypoxia upregulates HO-1 (12), elevated expression of this form of the enzyme is more likely to be responsible for the effect on contractility observed in our experiments. Furthermore, HO-1 expression is also enhanced by mechanical forces such as increased cyclic strain or shear stress in cultured vascular smooth muscle cells (22), although it is unclear whether a similar response is observed in intact endothelium. Although cardiac output does not appear to change following CH (1, 23), polycythemia associated with this stimulus could cause elevated shear stress on endothelial cells in the systemic vasculature, thereby potentially contributing to an increase in HO-1 expression. Nevertheless, the specific isoform responsible for the physiological actions documented in our study could not be determined because of the ineffectiveness of available antibodies to HO-1 and HO-2 in Western blot analysis in aortic tissue (3). In the absence of definitive data demonstrating upregulation of HO enzyme in the vasculature following CH, an alternative possibility is that the level of vascular heme substrate is elevated under these conditions, thereby affecting enzyme activity. However, the extensive data illustrating enhanced expression of HO-1 under conditions associated with CH suggest that enhanced gene expression is more likely responsible for the current findings.
In summary, the current study provides evidence that the previously observed attenuation of vasoconstrictor reactivity following prolonged hypoxic exposure is partially due to the likely enhanced release of CO from the vascular endothelium.
| |
ACKNOWLEDGEMENTS |
|---|
The authors thank G. Herrera and S. Dais for their assistance.
| |
FOOTNOTES |
|---|
This work was supported by National Heart, Lung, and Blood Institute Grants HL-42778 (to B. R. Walker), T32-HL07736 (to T. K. Caudill), and 1-F32-HL09660 (to T. C. Resta); American Heart Association Grant-in-Aid NMGS-11-97 (to N. L. Kanagy); and a Fellowship from the American Heart Association, with funds contributed in part by the New Mexico Affiliate (to T. C. Resta).
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact.
Address for reprint requests: B. R. Walker, Vascular Physiology Group, Dept. of Cell Biology and Physiology, Univ. of New Mexico School of Medicine, 915 Camino de Salud, NE, Albuquerque, NM 87131-5218.
Received 23 January 1998; accepted in final form 26 June 1998.
| |
REFERENCES |
|---|
|
Top
Abstract
Introduction
Methods
Results
Discussion
References
|
|---|
1.
Banchero, N.
Cardiovascular responses to chronic hypoxia.
Annu. Rev. Physiol.
49:
465-476,
1987[Medline].
2.
Christodoulides, N.,
W. Durante,
M. H. Kroll,
and
A. I. Schafer.
Vascular smooth muscle cell heme oxygenases generate guanylyl cyclase-stimulatory carbon monoxide.
Circulation
91:
2036-2039,
1995
3.
Coceani, F.,
L. Kelsey,
E. Seidltiz,
G. S. Marks,
B. E. McLaughlin,
H. J. Vreman,
D. K Stevenson,
M. Rabinovitch,
and
C. Ackerley.
Carbon monoxide formation in the ductus arteriosus in the lamb: implications for the regulation of muscle tone.
Br. J. Pharmacol.
120:
599-608,
1997[Medline].
4.
Cook, M. N.,
K. Nakatsu,
G. Marks,
B. McLaughlin,
H. Vreman,
D. Stevenson,
and
J. Brien.
Heme oxygenase activity in the adult rat aorta and liver as measured by carbon monoxide formation.
Can. J. Physiol. Pharmacol.
73:
515-518,
1995[Medline].
5.
Doyle, M. P.,
and
B. R. Walker.
Attenuation of systemic vasoreactivity in chronically hypoxic rats.
Am. J. Physiol.
260 (Regulatory Integrative Comp. Physiol. 29):
R1114-R1122,
1991
6.
Harrison, G. L.,
I. F. McMurtry,
and
L. G. Moore.
Meclofenamate potentiates vasoreactivity to -adrenergic stimulation in chronically hypoxic guinea pigs.
Am. J. Physiol.
259 (Heart Circ. Physiol. 28):
H62-H67,
1990
7.
Hatake, K.,
I. Wakabayashi,
and
S. Hishida.
Endothelium-dependent relaxation resistant to NG-nitro-L-arginine in rat aorta.
Eur. J. Pharmacol.
274:
25-32,
1995[Medline].
8.
Heistad, D. D.,
F. M. Abboud,
A. L. Mark,
and
P. G. Schmid.
Impaired reflex vasoconstriction in chronically hypoxemic patients.
J. Clin. Invest.
51:
331-337,
1972.
9.
Hu, X.-Q.,
L. D. Longo,
R. D. Gilbert,
and
L. Zhang.
Effects of long-term altitude hypoxemia on 1-adrenergic receptors in the ovine uterine artery: function and binding studies.
Am. J. Physiol.
270 (Heart Circ. Physiol. 39):
H1001-H1007,
1996
10.
Hu, X.-Q.,
and
L. Zhang.
Chronic hypoxia suppresses pharmacomechanical coupling of the uterine artery in near term pregnant sheep.
J. Physiol. (Lond.)
499:
551-559,
1996
11.
Johnson, R.,
M. Lavesa,
B. Askari,
N. Abraham,
and
A. Nasjletti.
A heme oxygenase product, presumably carbon monoxide, mediates a vasodepressor function in rats.
Hypertension
25:
166-169,
1995
12.
Lee, P. J.,
B. Hiang,
B. Chin,
N. Iyer,
J. Alam,
G. Semenza,
and
A. Choi.
Hypoxia inducible factor-1 mediates transcriptional activation of the heme oxygenase gene in response to hypoxia.
J. Biol. Chem.
272:
5373-5381,
1997.
13.
Maines, M. D.
The heme oxygenase system: a regulator of second messenger gases.
Annu. Rev. Pharmacol. Toxicol.
37:
517-554,
1997[Medline].
14.
McGrath, J. J.,
and
D. L. Smith.
Response of rat coronary circulation to carbon monoxide and nitrogen hypoxia.
Proc. Soc. Exp. Biol. Med.
177:
132-136,
1984[Medline].
15.
Mian, R.,
and
J. M. Marshall.
The role of adenosine in mediating vasodilation in mesenteric circulation of the rat in acute and chronic hypoxia.
J. Physiol. (Lond.)
489.1:
225-234,
1995
16.
Morita, T.,
M. Perrella,
M. Lee,
and
S. Kourembanas.
Smooth muscle cell-derived carbon monoxide is a regulator of cGMP.
Proc. Natl. Acad. Sci. USA
92:
1475-1479,
1995
17.
Resta, T C.,
R. J. Gonzales,
W. G. Dail,
T. C. Sanders,
and
B. R. Walker.
Selective upregulation of arterial endothelial nitric oxide synthase in pulmonary hypertension.
Am. J. Physiol.
272 (Heart Circ. Physiol. 41):
H806-H813,
1997
18.
Suematsu, M.,
N. Goda,
T. Sano,
S. Kashawagi,
T. Egawa,
Y. Shinoda,
and
Y. Ishimura.
Carbon monoxide: an endogenous modulator of sinusoidal tone in the perfused rat liver.
J. Clin. Invest.
96:
2431-2437,
1995.
19.
Tateishei, J.,
and
J. E. Faber.
Inhibiton of arteriole 2-but not 1-adrenoceptor constriction by acidosis and hypoxia in vitro.
Am. J. Physiol.
268 (Heart Circ. Physiol. 37):
H2068-H2076,
1995
20.
Vedernikov, Y. P.,
T. Graser,
and
A. F. Vanin.
Similar endothelium-independent arterial relaxation by carbon monoxide and nitric oxide.
Biomed. Biochim. Acta
48:
601-603,
1989[Medline].
21.
Verma, A.,
D. J. Hirsch,
C. E. Glatt,
G. V. Ronnett,
and
S. H. Snyder.
Carbon monoxide: a putative neural messenger.
Science
259:
381-384,
1993
22.
Wagner, C. T.,
W. Durante,
N. Christodoulides,
and
A. I. Schafer.
Hemodynamic forces induce the expression of heme oxygenase in cultured vascular smooth muscle cells.
J. Clin. Invest.
100:
589-596,
1997[Medline].
23.
Wolfel, E. E.,
B. M. Groves,
G. A. Brooks,
G. E. Butterfield,
R. S. Mazzeo,
L. G. Moore,
J. R. Sutton,
P. R. Bender,
T. E. Dahms,
R. E. McCullough,
R. G. McCullough,
S.-Y. Huang,
S.-F. Sun,
R. F. Grover,
H. N. Hultgren,
and
J. T. Reeves.
Oxygen transport during steady-state submaximal exercise in chronic hypoxia.
J. Appl. Physiol.
70:
1129-1136,
1991
24.
Yet, S.-F.,
A. Pellacani,
C. Patterson,
L. Tan,
S. C. Folta,
L. Foster,
W.-S. Lee,
C.-M. Hsieh,
and
M. A. Perella.
Induction of heme oxygenase-1 expression in vascular smooth muscle cells.
J. Biol. Chem.
272:
4295-4301,
1997
25.
Zakhary, R.,
S. Gaine,
J. Dinerman,
M. Ruat,
N. Flavahan,
and
S. Snyder.
Heme oxygenase 2: endothelial and neuronal localization and role in endothelium-dependent relaxation.
Proc. Natl. Acad. Sci. USA
93:
795-798,
1996
This article has been cited by other articles:
|
|
 |
|
  W. J. Pearce, J. M. Williams, C. R. White, and T. M. Lincoln Effects of chronic hypoxia on soluble guanylate cyclase activity in fetal and adult ovine cerebral arteries J Appl Physiol, July 1, 2009; 107(1): 192 - 199. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. W. Ryter, J. Alam, and A. M. K. Choi Heme Oxygenase-1/Carbon Monoxide: From Basic Science to Therapeutic Applications Physiol Rev, April 1, 2006; 86(2): 583 - 650. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. W. Leffler, H. Parfenova, J. H. Jaggar, and R. Wang Carbon monoxide and hydrogen sulfide: gaseous messengers in cerebrovascular circulation J Appl Physiol, March 1, 2006; 100(3): 1065 - 1076. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Rebel, S. Cao, H. Kwansa, S. Dore, E. Bucci, and R. C. Koehler Dependence of acetylcholine and ADP dilation of pial arterioles on heme oxygenase after transfusion of cell-free polymeric hemoglobin Am J Physiol Heart Circ Physiol, March 1, 2006; 290(3): H1027 - H1037. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Govindaraju, H. Teoh, Q. Hamid, P. Cernacek, and M. E. Ward Interaction between endothelial heme oxygenase-2 and endothelin-1 in altered aortic reactivity after hypoxia in rats Am J Physiol Heart Circ Physiol, February 1, 2005; 288(2): H962 - H970. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Nishikawa, D. W. Stepp, D. Merkus, D. Jones, and W. M. Chilian In vivo role of heme oxygenase in ischemic coronary vasodilation Am J Physiol Heart Circ Physiol, June 1, 2004; 286(6): H2296 - H2304. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Zhang, J. I. Kaide, L. Yang, H. Jiang, S. Quan, R. Kemp, W. Gong, M. Balazy, N. G. Abraham, and A. Nasjletti CO modulates pulmonary vascular response to acute hypoxia: relation to endothelin Am J Physiol Heart Circ Physiol, January 1, 2004; 286(1): H137 - H144. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. S. Naik and B. R. Walker Heme oxygenase-mediated vasodilation involves vascular smooth muscle cell hyperpolarization Am J Physiol Heart Circ Physiol, June 5, 2003; 285(1): H220 - H228. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. S. Naik, T. L. O'Donaughy, and B. R. Walker Endogenous carbon monoxide is an endothelial-derived vasodilator factor in the mesenteric circulation Am J Physiol Heart Circ Physiol, March 1, 2003; 284(3): H838 - H845. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Earley and B. R. Walker Endothelium-dependent blunting of myogenic responsiveness after chronic hypoxia Am J Physiol Heart Circ Physiol, December 1, 2002; 283(6): H2202 - H2209. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Samb, C. Taille, A. Almolki, J. Megret, J. M. Staddon, M. Aubier, and J. Boczkowski Heme oxygenase modulates oxidant-signaled airway smooth muscle contractility: role of bilirubin Am J Physiol Lung Cell Mol Physiol, September 1, 2002; 283(3): L596 - L603. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Earley, J. S. Naik, and B. R. Walker 48-h Hypoxic exposure results in endothelium-dependent systemic vascular smooth muscle cell hyperpolarization Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2002; 283(1): R79 - R85. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. J. Gonzales and B. R. Walker Role of CO in attenuated vasoconstrictor reactivity of mesenteric resistance arteries after chronic hypoxia Am J Physiol Heart Circ Physiol, January 1, 2002; 282(1): H30 - H37. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. S. Naik and B. R. Walker Homogeneous segmental profile of carbon monoxide-mediated pulmonary vasodilation in rats Am J Physiol Lung Cell Mol Physiol, December 1, 2001; 281(6): L1436 - L1443. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. L. Jernigan, T. L. O'Donaughy, and B. R. Walker Correlation of HO-1 expression with onset and reversal of hypoxia-induced vasoconstrictor hyporeactivity Am J Physiol Heart Circ Physiol, July 1, 2001; 281(1): H298 - H307. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Zhang, J.-I. Kaide, Y. Wei, H. Jiang, C. Yu, M. Balazy, N. G. Abraham, W. Wang, and A. Nasjletti Carbon monoxide produced by isolated arterioles attenuates pressure-induced vasoconstriction Am J Physiol Heart Circ Physiol, July 1, 2001; 281(1): H350 - H358. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. L. O'Donaughy and B. R. Walker Renal vasodilatory influence of endogenous carbon monoxide in chronically hypoxic rats Am J Physiol Heart Circ Physiol, December 1, 2000; 279(6): H2908 - H2915. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. R. Grover, R. L. Rairigh, J. P. Zenge, S. H. Abman, and J. P. Kinsella Inhaled carbon monoxide does not cause pulmonary vasodilation in the late-gestation fetal lamb Am J Physiol Lung Cell Mol Physiol, April 1, 2000; 278(4): L779 - L784. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. D. Appleton, G. S. Marks, K. Nakatsu, J. F. Brien, G. N. Smith, and C. H. Graham Heme oxygenase activity in placenta: direct dependence on oxygen availability Am J Physiol Heart Circ Physiol, June 1, 2002; 282(6): H2055 - H2059. [Abstract] [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
)
(n = 7) and chronically hypoxic (CH)
(
) (n = 6) rats. Data are means ± SE. * P < 0.05 vs. control.
) or L-NNA and
vehicle (
) or L-NNA and
vehicle (
